TY  - GEN
AU  - Buurman,D J
AU  - Blokzijl,T
AU  - Festen,E A M
AU  - Pham,B T
AU  - Faber,K N
AU  - Brouwer,E
AU  - Dijkstra,G
TI  - Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar
SN  - 1932-6203
PY  - 2019///0508
KW  - Adalimumab
KW  - administration & dosage
KW  - Adult
KW  - Aged
KW  - Antibodies, Anti-Idiotypic
KW  - blood
KW  - Antibodies, Monoclonal
KW  - Antibodies, Neutralizing
KW  - Biological Products
KW  - Biosimilar Pharmaceuticals
KW  - Certolizumab Pegol
KW  - Cross Reactions
KW  - immunology
KW  - Etanercept
KW  - Female
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1371/journal.pone.0208922
ER  -